ahlam1399
08-05-2015, 12:05 AM
FDA to revise **vartis? Gilenya label to reflect brain infection risk
(Reuters) - The U.S. Food and Drug Administration said it will update the label of **vartis AG's multiple sclerosis drug, Gilenya, after cases of serious brain infections were linked with its use.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/48b4723f/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=xdgA62l_TAk:MLD4ZzM4kVk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xdgA62l_TAk:MLD4ZzM4kVk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=xdgA62l_TAk:MLD4ZzM4kVk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xdgA62l_TAk:MLD4ZzM4kVk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=xdgA62l_TAk:MLD4ZzM4kVk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/xdgA62l_TAk
(Reuters) - The U.S. Food and Drug Administration said it will update the label of **vartis AG's multiple sclerosis drug, Gilenya, after cases of serious brain infections were linked with its use.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/48b4723f/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=xdgA62l_TAk:MLD4ZzM4kVk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xdgA62l_TAk:MLD4ZzM4kVk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=xdgA62l_TAk:MLD4ZzM4kVk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xdgA62l_TAk:MLD4ZzM4kVk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=xdgA62l_TAk:MLD4ZzM4kVk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/xdgA62l_TAk